J Korean Soc Transplant.  1999 Jun;13(1):101-108.

Tacrolimus (FK506) for Rescue Therapy of Refractory Renal Allograft Rejection

Affiliations
  • 1Department of Surgery, University of Ulsan College of Medicine, Korea.
  • 2Department of Surgery, Asan Medical Center & Kangnung Hospital, Korea.

Abstract

Over the 1 year 3 month period from 7/11/1997 until 10/30/1998, we have attempted graft salvage with tacrolimus conversion in a total of 11 patients (mean age 41 years, range 31~64 years) with ongoing rejection on baseline CsA immunosuppression after failure of high dose corticosteroid to reverse rejection. The indications for conversion to tacrolimus were ongoing biosy confirmed rejection in all patients. Seven grafts showed vascular rejection and 4 had cellular rejection on biopsy. The median interval to tacrolimus conversion was 4 days (range 1 days to 840 days) after transplantation. Three patients (27.3%) were dialysis-dependent owing to the severity of rejection. All patients (100%) have been successfully rescued and graft function of the patients improved from an average serum creatinine level of 7.3 3.6 mg/dl to 1.4 0.5 mg/dl. During the mean follow-up of 8.1 months after conversion, there were 10 complications following tacrolimus conversion including cytomegalovirus (CMV) infection in 2 patient, herpes esophagitis in 1, aspergillosis pneumonia in 1, pneumocystis carinii pneumonia in 1, new-onset diabetes mellitus in 4, tremor in 1 and bleeding due to thrombocytopenic thrombocytopenic purpura (TTP) in 1. Two of these postconversion complications resulted in patient death. Treatment with tacrolimus may successfully suppress ongoing acute rejection, even if high dose corticosteoid treatment have failed to reverse rejection. Base on these data, we recommend that tacrolimus be used for refractory rejection therapy. An additional anti-infective prophylaxis seems to be necessary in preventing severe complications after rejection therapy.

Keyword

Tacrolimus; Refractory rejection therapy

MeSH Terms

Allografts*
Aspergillosis
Biopsy
Creatinine
Cytomegalovirus
Diabetes Mellitus
Esophagitis
Follow-Up Studies
Hemorrhage
Humans
Immunosuppression
Pneumonia
Pneumonia, Pneumocystis
Purpura, Thrombocytopenic
Tacrolimus*
Transplants
Tremor
Creatinine
Tacrolimus
Full Text Links
  • JKSTN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr